9 Festivals to Celebratein August in India
August 8, 2025
Guru Randhawa – SIRRA ( Official Video )
July 1, 2025
New Delhi, Strides Pharma Science Ltd on Saturday announced divestment of majority stake in its wholly-owned arm Pivot Path for Rs 100 crore to a consortium of investors led ...
New Delhi: Alembic Pharmaceuticals Ltd on Friday said it has received final approval from the US health regulator for its generic version of oseltamivir phosphate for oral suspension indicated ...
New Delhi: Alembic Pharmaceuticals Ltd on Friday said it has received tentative approval from the US health regulator for its generic version of cancer treatment drug Binimetinib tablets.The tentative ...
New Delhi, Uzbekistan could offer enhanced subsidies and technology transfer incentives to encourage greater investment from Indian pharmaceutical companies, strengthening its position as a regional hub for pharmaceutical manufacturing ...
Indian pharmaceutical companies are strategically pivoting their US market approach, deepening investments in high-value specialty drugs, complex therapies, and local manufacturing to counter pricing pressures and intensifying competition in ...
Sun Pharmaceutical Industries reported robust consolidated financial results for Q4 FY26, showcasing significant profit and revenue growth, even as its crucial US generics business continues to face challenges, prompting ...
New Delhi: India's drug regulatory authority-Central Drugs Standard Control Organisation (CDSCO) has issued a fresh directive tightening post marketing safety reporting requirements for manufacturers and importers of new drugs.The ...
Indian benchmark stock indices Sensex and Nifty staged a significant rebound, snapping a three-day losing streak, fuelled by strong performances from Reliance Industries and Sun Pharma, coupled with positive ...
Mumbai: Dilip Shanghvi is going ahead with his biggest bet ever, by submitting a binding offer of $13 billion to acquire US-based Organon & Co, said people in the ...
The Indian pharmaceutical and healthcare sector is expected to see moderate revenue growth, with EBITDA margins remaining flat, in the March quarter, according to a brokerage report by HDFC ...
Copyright © 2021 - India News Online.







